Poorer nations shun AstraZeneca Covid vaccine: Document

For the six months, poorer nations asked for only around half a million doses of the AstraZeneca Covishield vaccine produced by the Serum Institute of India, which COVAX had initially regarded as its main supplier.

Poorer nations have refused tens of millions of AstraZeneca Covid-19 vaccines from the global programme COVAX, a document shows, the latest sign that its short shelf life is sapping demand for the shot.